Latest Thalidomide Stories

When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment. In a new study, researchers from the University of Bologna, Italy, demonstrate that Thal-Dex (thalidomide used in combination with dexamethasone) is more powerful than conventional chemotherapy for the treatment of multiple myeloma. Their findings will be published in the July 1, 2005, issue of Blood, the...

WARREN, N.J., Dec. 1 /PRNewswire-FirstCall/ -- Celgene Corporation announced today that clinical investigators from leading cancer research centers will present data from recent and on-going clinical trials of REVLIMID in multiple myeloma, myelodysplastic syndromes, other malignant blood disorders, as well as its mechanism of action at the American Society of Hematology 46TH Annual Meeting, one of the largest oncology meetings in the world, in San Diego, CA from December 2-7, 2004. The...